ArticleThe Journal of infectious diseases2022

SARS-CoV-2 Variant Exposures Elicit Antibody Responses With Differential Cross-Neutralization of Established and Emerging Strains Including Delta and Omicron.

Matthew T Laurie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.